Monroe Capital slashes quarterly dividend 64% to $0.20—portfolio stress mounts

Monroe Capital Corporation cut its quarterly dividend to $0.20 per share from $0.55, a 64% reduction that marks the sharpest payout compression among business development companies this year. The Chicago-based BDC, which manages $2.1 billion in assets across 127 portfolio companies, announced the cut without warning late Thursday, sending shares down 11% in after-hours trading to $6.82.

The firm deployed $847 million across middle-market credits in 2024, primarily to companies with $10 million to $100 million in EBITDA. Monroe's portfolio weighted average yield stands at 11.4%, but non-accrual assets climbed to 4.2% of total investments in Q4 from 2.1% the prior quarter. Three holdings—two industrial distribution firms and one healthcare services provider—moved to non-accrual status in December, representing $89 million in combined exposure. The firm has not disclosed which portfolio companies triggered the classification.

The cut reflects structural strain in the lower middle market, where $500 million to $2 billion enterprise value companies face refinancing pressure as $380 billion in leveraged loans mature through 2026. Monroe's portfolio companies carry average net leverage of 5.2x EBITDA, elevated compared to the 4.6x average among publicly traded BDCs. Management cited "elevated portfolio volatility and the need to preserve capital" in a prepared statement, language that typically precedes additional non-accruals or outright write-downs.

The move places Monroe in a subset of 14 BDCs that have reduced dividends by more than 50% since 2022. Peers managing similar credit profiles—FS KKR Capital, Owl Rock Capital—have maintained payouts, suggesting Monroe's stress is idiosyncratic rather than sector-wide. The firm's net asset value per share declined to $9.14 in Q4 from $9.68 in Q3, a 5.6% drop driven by markdown activity across 11 positions. Monroe has not disclosed whether the marked-down credits overlap with the non-accrual additions.

Allocators should monitor Monroe's Q1 earnings in early May for revised non-accrual figures and whether management initiates asset sales to stabilize NAV. The firm's $420 million credit facility matures in November 2025, and covenant headroom has tightened to 18% based on the latest filings. If non-accruals exceed 6% of the portfolio, Monroe risks breaching leverage covenants, forcing accelerated deleveraging. Three portfolio companies are scheduled for refinancing between March and June, and those outcomes will clarify whether the stress is contained or systemic.

Monroe's board meets quarterly, and the next decision point on the dividend arrives in late April. The yield, now 11.7% at the reduced payout, still exceeds the BDC sector median of 9.3%, but only if the dividend holds.